Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

NeuroControl

This article was originally published in The Gray Sheet

Executive Summary

Firm receives humanitarian use designation for its Vocare bladder system, which is intended for individuals with complete spinal cord injuries. Vocare uses functional electrical stimulation technology to deliver electrical impulses to nerve roots leading to bladder and bowel muscles, helping those with complete spinal cord injuries to control the loss of bladder and bowel functions. Since the commencement of clinical trials in mid-1996 ("The Gray Sheet" May 13, 1996, I&W-5), twenty-six people have been implanted with the device, the firm says. NeuroControl estimates approximately 73,000 people in the U.S. could potentially benefit from the product...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT010270

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel